Parallel Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56K | Hold |
149
| – | – | ﹤0.01% | 2834 |
|
|
2025
Q1 | $3.7K | Hold |
149
| – | – | ﹤0.01% | 2771 |
|
|
2024
Q4 | $2.81K | Buy |
149
+122
| +452% | +$2.3K | ﹤0.01% | 2825 |
|
|
2024
Q3 | $406 | Buy |
+27
| New | +$406 | ﹤0.01% | 3197 |
|
|
2024
Q2 | – | Sell |
-223
| Closed | -$6.52K | – | 3387 |
|
|
2024
Q1 | $6.52K | Sell |
223
-57
| -20% | -$1.67K | ﹤0.01% | 2448 |
|
|
2023
Q4 | $9.45K | Buy |
280
+220
| +367% | +$7.42K | ﹤0.01% | 2315 |
|
|
2023
Q3 | $1.84K | Buy |
60
+58
| +2,900% | +$1.78K | ﹤0.01% | 2850 |
|
|
2023
Q2 | $80 | Sell |
2
-31
| -94% | -$1.24K | ﹤0.01% | 3293 |
|
|
2023
Q1 | $1.35K | Buy |
+33
| New | +$1.35K | ﹤0.01% | 2887 |
|
|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 3480 |
|
|
2022
Q3 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 3398 |
|
|
2022
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 3252 |
|